ArticleOncotarget2018
The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomas.
Philip Carter et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleOncotarget2018
Philip Carter et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.